You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

SGLT2 Versus GLP1 for Cardiovascular Prevention

Annals on Call

In this episode of Annals On Call, Dr. Centor discusses the use of sodium–glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes with Dr. Elisabetta Patorno.

First, listen to the podcast. After listening, ACP members can take the CME/MOC quiz for free.

CME/MOC:

Up to 1 AMA PRA Category 1 Credits ™ and MOC Points
Expires December 21, 2024   active

Cost:

Free to Members

Format:

Podcasts and Audio Content

Product:

Annals on Call

Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.